DK1109571T3 - Fremgangsmåde til behandling af saltafhængig hypertension - Google Patents
Fremgangsmåde til behandling af saltafhængig hypertensionInfo
- Publication number
- DK1109571T3 DK1109571T3 DK99968631T DK99968631T DK1109571T3 DK 1109571 T3 DK1109571 T3 DK 1109571T3 DK 99968631 T DK99968631 T DK 99968631T DK 99968631 T DK99968631 T DK 99968631T DK 1109571 T3 DK1109571 T3 DK 1109571T3
- Authority
- DK
- Denmark
- Prior art keywords
- dependent hypertension
- treating salt
- methods
- compositions
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9969498P | 1998-09-09 | 1998-09-09 | |
US12640699P | 1999-03-26 | 1999-03-26 | |
US12661599P | 1999-03-27 | 1999-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1109571T3 true DK1109571T3 (da) | 2004-06-21 |
Family
ID=27378887
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99946776T DK1112083T3 (da) | 1998-09-09 | 1999-09-09 | Behandling af mikrovaskulære angiopatier |
DK99968631T DK1109571T3 (da) | 1998-09-09 | 1999-09-09 | Fremgangsmåde til behandling af saltafhængig hypertension |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99946776T DK1112083T3 (da) | 1998-09-09 | 1999-09-09 | Behandling af mikrovaskulære angiopatier |
Country Status (13)
Country | Link |
---|---|
US (3) | US6352975B1 (da) |
EP (2) | EP1109571B1 (da) |
JP (2) | JP2002532382A (da) |
AT (2) | ATE253934T1 (da) |
AU (2) | AU5910599A (da) |
BR (2) | BR9913564A (da) |
CA (2) | CA2340728C (da) |
DE (2) | DE69912815T2 (da) |
DK (2) | DK1112083T3 (da) |
ES (2) | ES2211165T3 (da) |
IL (2) | IL141687A0 (da) |
PT (2) | PT1112083E (da) |
WO (2) | WO2000013702A2 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2211165T3 (es) * | 1998-09-09 | 2004-07-01 | Scios Inc. | Uso de un factor angiogenico para el tratamiento de angiopatias microvasculares. |
US6783954B2 (en) * | 1999-03-05 | 2004-08-31 | Compugen Ltd. | VEGF nucleic acid and amino acid sequences |
WO2001032695A2 (en) * | 1999-11-02 | 2001-05-10 | Genentech, Inc. | MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
US7078382B1 (en) | 1999-11-02 | 2006-07-18 | Genentech, Inc. | Modulation of eNOS activity and therapeutic uses thereof |
US20030129251A1 (en) | 2000-03-10 | 2003-07-10 | Gary Van Nest | Biodegradable immunomodulatory formulations and methods for use thereof |
US7129222B2 (en) * | 2000-03-10 | 2006-10-31 | Dynavax Technologies Corporation | Immunomodulatory formulations and methods for use thereof |
GB0008269D0 (en) | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
AU2002317333C1 (en) | 2001-08-01 | 2009-06-25 | University Of Bristol | VEGF isoform |
EP1427323A4 (en) * | 2001-08-20 | 2004-09-15 | Univ Virginia | USE OF S-NITROSOTHIOL SIGNALING TO TREAT BREATH CONTROL DISORDERS |
US7981863B2 (en) * | 2001-09-19 | 2011-07-19 | Neuronova Ab | Treatment of Parkinson's disease with PDGF |
US7795213B2 (en) | 2001-12-13 | 2010-09-14 | Posco | Methods of contacting β amyloid protein with VEGF |
US20030171556A1 (en) * | 2001-12-13 | 2003-09-11 | Chi-Bom Chae | Beta-amyloid binding factors and inhibitors thereof |
US7335362B2 (en) | 2002-07-19 | 2008-02-26 | Beth Israel Deaconess Medical Center | Methods of treating pre-eclampsia or eclampsia |
JP2006068401A (ja) * | 2004-09-03 | 2006-03-16 | Kyushu Institute Of Technology | 人工血管 |
US7893244B2 (en) * | 2005-04-12 | 2011-02-22 | Intradigm Corporation | Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
BRPI0610499A2 (pt) * | 2005-04-12 | 2010-06-22 | Intradigm Corp | moléculas de ácido nucléico , composições e usos das referidas moléculas |
US8440619B2 (en) * | 2005-08-31 | 2013-05-14 | National University Corporation Kagawa University | Utilization of hypertension/hypercardia-preventing effect of D-allose |
ES2600781T3 (es) * | 2008-12-04 | 2017-02-10 | Curna, Inc. | Tratamiento para enfermedades relacionadas con el factor de crecimiento del endotelio vascular (vegf) mediante la inhibición de transcritos antisentido naturales de vegf |
GB0921525D0 (en) | 2009-12-08 | 2010-01-27 | Isis Innovation | Product and method |
EP3600251A4 (en) | 2017-03-30 | 2021-01-13 | Wake Forest University Health Sciences | METHOD OF TREATMENT OF KIDNEY DISEASE |
CN113418940B (zh) * | 2021-06-24 | 2023-03-14 | 电子科技大学 | 一种基于x射线示踪颗粒的检测方法及检测装置 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4456550A (en) | 1982-11-22 | 1984-06-26 | President And Fellows Of Harvard College | Vascular permeability factor |
US5240848A (en) | 1988-11-21 | 1993-08-31 | Monsanto Company | Dna sequences encoding human vascular permeability factor having 189 amino acids |
JP3549202B2 (ja) | 1989-03-24 | 2004-08-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 内皮細胞成長因子、その分離および発現 |
US5332671A (en) | 1989-05-12 | 1994-07-26 | Genetech, Inc. | Production of vascular endothelial cell growth factor and DNA encoding same |
US5194596A (en) | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
US5219739A (en) | 1989-07-27 | 1993-06-15 | Scios Nova Inc. | DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121 |
US5240714A (en) * | 1989-08-29 | 1993-08-31 | Rof Jose M S | Non-digoxin-like Na+, K+ -ATPase inhibitory factor |
US5318957A (en) * | 1992-09-02 | 1994-06-07 | The United States Of America As Represented By The Department Of Health And Human Services | Method of stimulating angiogenesis |
JP2001503755A (ja) * | 1996-11-01 | 2001-03-21 | ユーロジーン・リミテッド | Noまたはプロスタサイクリン産生を刺激する薬剤の治療的使用およびデリバリー装置 |
US6485942B1 (en) * | 1997-02-14 | 2002-11-26 | Genentech, Inc. | Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production |
ES2211165T3 (es) * | 1998-09-09 | 2004-07-01 | Scios Inc. | Uso de un factor angiogenico para el tratamiento de angiopatias microvasculares. |
-
1999
- 1999-09-09 ES ES99946776T patent/ES2211165T3/es not_active Expired - Lifetime
- 1999-09-09 IL IL14168799A patent/IL141687A0/xx unknown
- 1999-09-09 BR BR9913564-7A patent/BR9913564A/pt not_active Application Discontinuation
- 1999-09-09 BR BR9913533-7A patent/BR9913533A/pt not_active Application Discontinuation
- 1999-09-09 DK DK99946776T patent/DK1112083T3/da active
- 1999-09-09 DE DE69912815T patent/DE69912815T2/de not_active Expired - Fee Related
- 1999-09-09 JP JP2000568511A patent/JP2002532382A/ja active Pending
- 1999-09-09 AU AU59105/99A patent/AU5910599A/en not_active Abandoned
- 1999-09-09 WO PCT/US1999/020480 patent/WO2000013702A2/en active IP Right Grant
- 1999-09-09 CA CA002340728A patent/CA2340728C/en not_active Expired - Fee Related
- 1999-09-09 CA CA002340320A patent/CA2340320C/en not_active Expired - Fee Related
- 1999-09-09 PT PT99946776T patent/PT1112083E/pt unknown
- 1999-09-09 WO PCT/US1999/020481 patent/WO2000013703A2/en active IP Right Grant
- 1999-09-09 AT AT99946776T patent/ATE253934T1/de not_active IP Right Cessation
- 1999-09-09 DE DE69915310T patent/DE69915310T2/de not_active Expired - Fee Related
- 1999-09-09 IL IL14168699A patent/IL141686A0/xx unknown
- 1999-09-09 DK DK99968631T patent/DK1109571T3/da active
- 1999-09-09 JP JP2000568510A patent/JP2002524421A/ja active Pending
- 1999-09-09 AT AT99968631T patent/ATE260675T1/de not_active IP Right Cessation
- 1999-09-09 EP EP99968631A patent/EP1109571B1/en not_active Expired - Lifetime
- 1999-09-09 AU AU60285/99A patent/AU6028599A/en not_active Abandoned
- 1999-09-09 ES ES99968631T patent/ES2216630T3/es not_active Expired - Lifetime
- 1999-09-09 PT PT99968631T patent/PT1109571E/pt unknown
- 1999-09-09 US US09/392,932 patent/US6352975B1/en not_active Expired - Lifetime
- 1999-09-09 EP EP99946776A patent/EP1112083B1/en not_active Expired - Lifetime
-
2002
- 2002-02-26 US US10/083,817 patent/US20020193288A1/en not_active Abandoned
-
2003
- 2003-12-31 US US10/749,706 patent/US20040224885A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1109571T3 (da) | Fremgangsmåde til behandling af saltafhængig hypertension | |
DK1202724T3 (da) | Fremgangsmåde til behandling af kronisk smerte under anvendelse af mek-inhibitorer | |
BR9707819A (pt) | Imunogenos peptidicos | |
DK1231887T3 (da) | Fremgangsmåde og sammensætning til behandling af ar | |
DK0912535T3 (da) | Konjugater af cis-docosahexaensyre og paclitaxel | |
DK1123313T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi | |
DK0914116T3 (da) | Kompositstoffer omfattende konjugater af cis-docosahexaensyre og Taxotere | |
TR200101481T2 (tr) | Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi. | |
DK1144474T3 (da) | Vandig reaktiv spartelmasse | |
DE69813898D1 (de) | Substituierte porphyrinen | |
PT1322696E (pt) | Composicoes que compreendem um notroxido, um promotor e eventualmente um iniciador de radicais livres | |
TR199701669A1 (xx) | Deri preparasyonu i�in bile�imler. | |
DK1427409T3 (da) | Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer | |
DK1411916T3 (da) | Fremgangsmåder og materialer til behandling af testosteronmangel hos mænd | |
DK0967987T3 (da) | Sammensætning til behandling af tumorer indeholdende hajbruskekstrakter og anitneoplastiske stoffer | |
TR199901703T2 (xx) | Siklooksijenaz-2 inhibit�rlerini anti-anjiyojenik ajanlar olarak kullanma y�ntemi. | |
DE69627702D1 (de) | Stabilisierte, korrosionsinhibierte feuerhemmende zusammensetzungen und methoden | |
WO2002063003A3 (en) | Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof | |
DK0880569T3 (da) | Kompositioner til behandling af jord, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
WO2002041831A3 (en) | Inositol derivatives for increasing chloride secretion and inhibiting inflammation | |
DK1143917T3 (da) | Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom | |
DK1303294T3 (da) | Fremgangsmåde til behandling af instabil angina pectoris | |
ATE270113T1 (de) | Zusammenstellungen zur verbesserten wundheilung | |
PT950056E (pt) | N-(piridinilamino) isoindolinas e compostos relacionados | |
EP1447089A3 (en) | Methods of treating hypertension and compositions for use therein |